Delivery Order SPE2DR25D2005-SPE2DR26FE7J8
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of IMOVAX Rabies Vaccine vials on September 10, 2025. This competitively awarded, firm fixed-price contract carries a ceiling value of $2,286.87 and has an ultimate completion date of September 11, 2025. The vaccine will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a $1,376.21 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of IMOVAX Rabies Vaccine vials. The contract, which is a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), requires completion by July 28, 2025. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 7, 2025, for the supply of IMOVAX Rabies Vaccine Vials, with a ceiling value of $4,133.00 and an ultimate completion date of June 9, 2025. This is a firm fixed-price, non-set-aside contract performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $9,325.08 to AmerisourceBergen Drug Corp for the supply of IMOVAX Rabies Vaccine vials. This firm fixed price delivery order, issued on November 18, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of IMOVAX Rabies Vaccine Vials, with a contract ceiling value of $5,391.25 and an ultimate completion date of November 13, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's broader Indefinite...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,568.75 for IMOVAX Rabies Vaccine vials on August 18, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price contract, which is not set-aside, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,113.75 to AmerisourceBergen Drug Corp for IMOVAX Rabies Vaccine Vials, with a completion date of April 25, 2025. This firm fixed price contract, awarded on April 24, 2025, represents a competitively awarded, non-set-aside procurement supporting federal medical supply requirements. The vaccine will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,924.74 on August 29, 2025, for the supply of IMOVAX Rabies Vaccine Vials. The contract is competitively awarded with no set-aside designation and employs firm fixed price terms, with an ultimate completion date of September 2, 2025. Performance will take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- The Defense Logistics Agency awarded a Delivery Order valued at $4,315.56 to AmerisourceBergen Drug Corp for IMOVAX Rabies Vaccine Vials, with a firm fixed price contract type. The award was made on July 28, 2025, with an ultimate completion date of July 29, 2025. This delivery order represents a non-set-aside competitive award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract reflects DLA's ongoing pharmaceutical procurement needs...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of IMOVAX Rabies Vaccine Vials with a ceiling value of $2,156.50. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award carries no set-aside designation and was competitively awarded. Performance...
- SPE2DR25D2005Indefinite Delivery Contract
- SPE2DR25D2005-SPE2DR26FE7J8Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,391.25 to AmerisourceBergen Drug Corp for the supply of IMOVAX Rabies Vaccine Vials. This firm fixed-price delivery order, issued on November 24, 2025, with an ultimate completion date of November 25, 2025, represents a non-competitive child award under AmerisourceBergen's larger indefinite delivery contract with DLA. The vaccine will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary operations for federal medical procurement. This delivery order falls under AmerisourceBergen's substantial $999.999 billion indefinite delivery contract with DLA Troop Support Medical (SPE2DX), which extends through December 2026 and serves as a global pharmaceutical support vehicle for military healthcare programs. As a major pharmaceutical distributor and established federal medical vendor, AmerisourceBergen leverages this prime contract to supply vaccines, medications, and medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The rabies vaccine delivery exemplifies the company's critical role in supporting the medical supply chain for U.S. military and federal health operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.4k | 11/23/25 |